Star Therapeutics

Star Therapeutics is developing next generation immunotherapies to transform the lives of patients with serious diseases. Unlike other drug development efforts that start with a specific biological target, Star is taking a unique approach that starts with identifying multiple diseases with common pathobiology. This logical approach enables Star to discover and develop therapeutics that can treat numerous diseases with a single therapy. Combined with Star’s expertise in developing human disease models to examine disease biology and preclinical efficacy, Star is strategically discovering and selecting high-potential antibody therapeutics with the promise to significantly improve patient lives.